See more : Lords & Company Worldwide Holdings Inc. (LRDSF) Income Statement Analysis – Financial Results
Complete financial analysis of SD BioSensor, Inc (137310.KS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SD BioSensor, Inc, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Canon Inc. (CAJ) Income Statement Analysis – Financial Results
- 3i Group plc (III.L) Income Statement Analysis – Financial Results
- Filo Mining Corp. (FLMMF) Income Statement Analysis – Financial Results
- ANS Industries Limited (ANSINDUS.BO) Income Statement Analysis – Financial Results
- Hotel Property Investments (HPI.AX) Income Statement Analysis – Financial Results
SD BioSensor, Inc (137310.KS)
About SD BioSensor, Inc
SD BioSensor Inc., an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company's products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decision making near-the-patient, which include analyzers, assay menus, qPCR reagents, and NA extraction kits; procell Dx, an in vitro diagnostic products for the diagnosis of infectious disease, such as tuberculosis and SARS-CoV-2, and for checking the immune status of individuals through the interferon gamma release assay; and blood glucose meters. The company was founded in 2010 and is headquartered in Suwon, South Korea.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 655.68B | 2,932.00B | 2,929.96B | 1,686.16B | 72.96B | 65.63B |
| Cost of Revenue | 533.23B | 1,539.01B | 1,359.93B | 828.00B | 52.15B | 45.60B |
| Gross Profit | 122.45B | 1,392.99B | 1,570.03B | 858.16B | 20.81B | 20.04B |
| Gross Profit Ratio | 18.68% | 47.51% | 53.59% | 50.89% | 28.52% | 30.53% |
| Research & Development | 64.20B | 45.76B | 18.89B | 10.39B | 4.87B | 4.27B |
| General & Administrative | 22.96B | 12.61B | 4.71B | 1.95B | 1.63B | 0.00 |
| Selling & Marketing | 88.12B | 75.69B | 123.98B | 79.98B | 4.54B | 0.00 |
| SG&A | 111.08B | 88.30B | 128.69B | 81.93B | 6.17B | 12.46B |
| Other Expenses | 198.81B | 112.31B | 58.41B | 27.58B | 8.25B | -275.54M |
| Operating Expenses | 374.09B | 246.37B | 205.99B | 119.90B | 19.29B | 17.00B |
| Cost & Expenses | 903.76B | 1,785.38B | 1,565.92B | 947.90B | 71.44B | 62.59B |
| Interest Income | 23.49B | 26.49B | 6.70B | 489.67M | 90.10M | 9.90M |
| Interest Expense | 49.23B | 994.06M | 488.66M | 433.63M | 251.49M | 235.38M |
| Depreciation & Amortization | 137.54B | 40.82B | 19.11B | 7.97B | 4.33B | 4.40B |
| EBITDA | -250.86B | 1,187.44B | 1,406.85B | 746.24B | 5.85B | 8.46B |
| EBITDA Ratio | -38.26% | 44.37% | 49.67% | 43.10% | 7.88% | 11.34% |
| Operating Income | -248.08B | 1,146.62B | 1,364.04B | 738.26B | 1.52B | 3.04B |
| Operating Income Ratio | -37.84% | 39.11% | 46.55% | 43.78% | 2.08% | 4.63% |
| Total Other Income/Expenses | -190.53B | 95.46B | 76.78B | -21.03B | -374.29M | 783.15M |
| Income Before Tax | -438.61B | 1,242.09B | 1,440.82B | 717.24B | 2.20B | 3.82B |
| Income Before Tax Ratio | -66.89% | 42.36% | 49.18% | 42.54% | 3.02% | 5.82% |
| Income Tax Expense | 29.29B | 333.30B | 376.38B | 95.62B | -928.64M | -142.11M |
| Net Income | -467.71B | 911.36B | 1,088.47B | 615.64B | 3.15B | 3.03B |
| Net Income Ratio | -71.33% | 31.08% | 37.15% | 36.51% | 4.32% | 4.62% |
| EPS | -4.22K | 9.00K | 11.16K | 5.99K | 30.68 | 29.50 |
| EPS Diluted | -4.22K | 9.00K | 11.16K | 5.99K | 30.68 | 29.50 |
| Weighted Avg Shares Out | 110.86M | 101.30M | 97.52M | 102.76M | 102.76M | 102.76M |
| Weighted Avg Shares Out (Dil) | 110.86M | 101.30M | 97.52M | 102.76M | 102.76M | 102.76M |
Source: https://incomestatements.info
Category: Stock Reports